Australia Health

Ramsay Health Care (ASX:RHC) announced a proposal to separate from its European subsidiary, Ramsay Santé.

Sonic Healthcare (ASX:SHL) announced its financial performance for the half-year ended Dec. 31, 2025, marked by double-digit revenue growth.

Medibank Group (ASX:MPL) reported a $297.8 million underlying net profit after tax for H1 FY26, a slight dip of 0.3%.

Telix Pharmaceuticals (ASX:TLX) submitted a Marketing Authorisation Application in Europe for its glioma imaging candidate, TLX101-Px.

Clinical-stage drug development company Nyrada (ASX:NYR) has released its half-year results for the 2026 fiscal year.

Mayne Pharma Group (ASX:MYX) has escalated its legal dispute with Cosette Pharmaceuticals, filing a substantial damages claim in the Supreme Court of New South Wales.

Biotech firm CSL (ASX:CSL) has entered into an exclusive licensing agreement with US pharmaceutical giant Eli Lilly and Company.

Healthcare giant Healius (ASX:HLS) saw H1 FY26 total revenue climb 3.8% to $688.1 million, driven largely by its core pathology division.

Clinical dermatology leader Botanix Pharmaceuticals (ASX:BOT) has secured firm commitments to raise approximately $45 million in new capital.

Rhythm Biosciences (ASX:RHY) entered into a strategic distribution service agreement with 4Cyte Pathology, one of Australia's largest independent pathology providers.

Australian Clinical Labs (ASX:ACL) announced its financial results for the first half of fiscal year 2026, showcasing a strategic shift toward "earnings quality".

BTC Health (ASX:BTC) landed an exclusive multi-year distribution agreement with global blood purification leader, Jafron Biomedical.